FDA and Purdue Pharmaceuticals have strengthened the warnings and precautions sections in the labeling of OxyContin, a narcotic drug approved for the treatment of moderate to severe pain, because of continuing reports of abuse and diversion. The changes are intended to reinforce proper prescription practices and increase physician focus on the potential for abuse, misuse, and diversion.
See the MedWatch 2001 Safety Summary for OxyContin at http://www.fda.gov/medwatch/safety/2001/safety01.htm#oxycon
-- --------------MedWatch is your Internet gateway for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration. Visit the MedWatch web site regularly for the latest official safety information, at http://www.fda.gov/medwatch